A carregar...
The Design and Synthesis of a New Class of RTK/HDAC Dual-Targeted Inhibitors
Over the years, the development of targeted medicines has made significant achievements. As a typical example, receptor tyrosine kinases (RTK) inhibitors have become important chemotherapy drugs for a variety of cancers. However, the effectiveness of these agents is always hindered by poor response...
Na minha lista:
| Publicado no: | Molecules |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6269723/ https://ncbi.nlm.nih.gov/pubmed/23736786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules18066491 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|